Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Caribou Biosciences (CRBU) Return on Equity (2020 - 2025)

Caribou Biosciences has reported Return on Equity over the past 6 years, most recently at 0.01% for Q4 2025.

  • Quarterly Return on Equity changed 0.0% to 0.01% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.01% for FY2025, 0.0% changed from the prior year.
  • Return on Equity was 0.01% for Q4 2025 at Caribou Biosciences, down from 0.01% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.01% in Q1 2021 and troughed at 0.01% in Q4 2025.
  • The 5-year median for Return on Equity is 0.0% (2021), against an average of 0.0%.
  • Year-over-year, Return on Equity decreased -2bps in 2021 and then changed 0bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 0.0% in 2021, then crashed by -102bps to 0.0% in 2022, then grew by 11bps to 0.0% in 2023, then crashed by -106bps to 0.01% in 2024, then plummeted by -80bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Return on Equity are 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025).